OXT and obesity due to melanocortin 4 receptor deficiency: To illustrate how oxytocin-based therapies can be applied in clinical settings, Figure 5 summarizes current delivery routes, associated challenges, and their relevance to treating vagus-related disorders such as dysphagia, obesity, and esophageal motility disturbances.